131 related articles for article (PubMed ID: 6996035)
1. Demonstration of PGI2 production by isolated perfused rat lungs with platelet aggregation test.
Hartiala J; Toivonen H; Uotila P
Prostaglandins; 1980 Jul; 20(1):127-34. PubMed ID: 6996035
[TBL] [Abstract][Full Text] [Related]
2. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
[TBL] [Abstract][Full Text] [Related]
3. The effect of ibuprofen dose on rabbit platelet aggregation and aortic pgi2 synthesis.
Adesuyi SA; Ellis EF
Thromb Res; 1982 Nov; 28(4):581-5. PubMed ID: 6761894
[No Abstract] [Full Text] [Related]
4. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
Reele SB; Miller OV; Spillers C; Gorman RR
Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
[TBL] [Abstract][Full Text] [Related]
5. Acceleration of endogeneous PGI2 generation from isolated rat aortae by MK-447.
Harada Y; Tanaka K; Katori M
Jpn J Pharmacol; 1981 Oct; 31(5):845-8. PubMed ID: 6796739
[No Abstract] [Full Text] [Related]
6. Prostaglandins as inhibitors of human platelet aggregation.
Di Minno G; Silver MJ; de Gaetano G
Br J Haematol; 1979 Dec; 43(4):637-47. PubMed ID: 393296
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of anaphylactic mediator release from guinea-pig perfused lungs by fatty acid hydroperoxides.
Adcock JJ; Garland LG; Moncada S; Salmon JA
Prostaglandins; 1978 Aug; 16(2):163-77. PubMed ID: 81494
[TBL] [Abstract][Full Text] [Related]
8. Exposure to carbon monoxide or to nicotine does not inhibit PGI2 formation by rat arterial rings incubated with human platelet-rich plasma.
Hartiala J; Simberg N; Uotila P
Artery; 1982; 10(6):412-9. PubMed ID: 6760833
[TBL] [Abstract][Full Text] [Related]
9. Influence of pH on the prostacyclin (PGI2) mediated inhibition of platelet function.
Rao GH; Reddy KR; Hagert K; White JG
Prostaglandins Med; 1980 Apr; 4(4):263-73. PubMed ID: 6994159
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of prostaglandins and an aortic proteoglycan on platelet aggregation and plasma clotting.
Ts'ao C; Eisenstein R
Prostaglandins Med; 1979 Sep; 3(3):159-66. PubMed ID: 399532
[TBL] [Abstract][Full Text] [Related]
11. Effect of dipyridamole on prostaglandin generation by human platelets and vessel walls.
Mehta J; Mehta P; Hay D
Prostaglandins; 1982 Dec; 24(6):751-61. PubMed ID: 6820166
[TBL] [Abstract][Full Text] [Related]
12. Effects of PGI2 on platelet aggregation induced by various stimulants.
Ohtsu A; Hoshina K; Kurozumi S; Hashimoto Y; Noguchi T; Nicolaou KC
Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):659-66. PubMed ID: 388963
[No Abstract] [Full Text] [Related]
13. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
Thromb Res; 1986 Feb; 41(4):509-18. PubMed ID: 3083526
[TBL] [Abstract][Full Text] [Related]
14. The metabolism of arachidonic acid to an antiaggregatory compound in isolated lungs of fetal and neonatal rabbits.
Simberg N; Hartiala J
Prostaglandins; 1982 Dec; 24(6):873-80. PubMed ID: 6820167
[TBL] [Abstract][Full Text] [Related]
15. Increased platelet activity after termination of prostacyclin infusion into man.
Dembinska-Kiec A; Zmuda A; Grodzinska L; Bieron K; Basista M; Kedzior A; Kostka-Trabka E; Telesz E; Zelazny T
Prostaglandins; 1981 May; 21(5):827-32. PubMed ID: 6803307
[TBL] [Abstract][Full Text] [Related]
16. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
[TBL] [Abstract][Full Text] [Related]
17. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
Landgraf-Leurs MM; Loy A; Christea C; Weber PC; Siess W; Herberg LL; Landgraf R
Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
[No Abstract] [Full Text] [Related]
18. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.
Ehrman ML; Jaffe EA
Prostaglandins; 1980 Dec; 20(6):1103-16. PubMed ID: 7010448
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet aggregation by a new agent, 5-(Z,E)-13,14-didehydro-20-methyl-carbo PGI2 (FCE 22509).
Bergamaschi M; Pierucci L; Ferti C; Corsi G; Branzoli U; Mandelli V
Prostaglandins Leukot Med; 1984 Oct; 16(1):19-27. PubMed ID: 6393142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
